Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/LIXTE-BIOTECHNOLOGY-HOLDI-302255/news/LIXTE-Biotechnology-Holdings-Inc-gibt-die-Aufnahme-des-ersten-Patienten-in-den-Phase-1b-Teil-des-P-44069771/?utm_source=whatsapp&utm_medium=social&utm_campaign=share